Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With HeberprovacJesús A. Junco, Marta Ayala, Ranfis Rodríguez et al.|Frontiers in Oncology|2019Cited by 19
Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidateJesús A. Junco, Gerardo Guillén, Héctor Hernández‐Vargas et al.|Vaccine|2007Cited by 19
Gonadotrophin Releasing Hormone-Based Vaccine, an Effective Candidate for Prostate Cancer and Other Hormone-sensitive NeoplasmsJesús A. Junco, Gerardo Guillén, Roberto Basalto et al.|Advances in experimental medicine and biology|2008Cited by 19
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrumLuis Ariel Espinosa, Luis Javier González, Yassel Ramos et al.|Analytical and Bioanalytical Chemistry|2021Cited by 17
Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer modelJesús Arturo Junco Barranco, Gerardo Guillén, Robert P. Millar et al.|Oncology Letters|2016Cited by 5